Clinical trials
Observational trials in Luxembourg
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
65 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 2 |
| 2006 | 1 |
| 2007 | 1 |
| 2008 | 3 |
| 2010 | 2 |
| 2011 | 5 |
| 2012 | 1 |
| 2013 | 3 |
| 2014 | 8 |
| 2015 | 3 |
| 2016 | 7 |
| 2017 | 4 |
| 2018 | 4 |
| 2019 | 1 |
| 2020 | 4 |
| 2021 | 3 |
| 2022 | 3 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 3 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 40 |
| Recruiting | 10 |
| Unknown status | 8 |
| Active, not recruiting | 3 |
| Terminated | 2 |
| Not yet recruiting | 1 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Luxembourg Institute of Health | 15 |
| Bayer | 6 |
| Centre Francois Baclesse, Luxembourg | 5 |
| Hoffmann-La Roche | 3 |
| Novo Nordisk A/S | 3 |
| AstraZeneca | 2 |
| Boehringer Ingelheim | 2 |
| Rigshospitalet, Denmark | 2 |
| Abbott | 1 |
| Abbott Medical Devices | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| COVID-19 | 4 |
| Diabetes Mellitus | 4 |
| Prostatic Neoplasms | 4 |
| Arthritis, Rheumatoid | 3 |
| Coronary Artery Disease | 3 |
| Acquired Immunodeficiency Syndrome | 2 |
| Anxiety Disorders | 2 |
| Carcinoma, Non-Small-Cell Lung | 2 |
| Cardiovascular Diseases | 2 |
| Colorectal Neoplasms | 2 |
Trials
Showing 26 to 50 of 65. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.